Skip to main content

Investor FAQs

Minerva Surgical trades on the Nasdaq exchange under the ticker symbol UTRS.

The Company’s headquarters is located Santa Clara, CA
4255 Burton Dr.
Santa Clara, CA 95054

The biographies of Minerva Surgical’s directors are available in the Board of Directors section of our Investor Relations website.

The biographies of Minerva Surgical’s management team are available in the Management Team section of our Investor Relations website.

Minerva Surgical’s fiscal year ends December 31st.

Minerva Surgical’s independent auditor is BDO USA, LLP.

Minerva Surgical’s outside legal counsel is Wilson Sonsini Goodrich & Rosati.

No, Minerva Surgical does not pay a dividend at this time.

No, Minerva Surgical does not offer a direct stock purchase program.

Minerva Surgical’s quarterly and annual reports and other SEC filings are available by selecting the Financials & Filings section of our “Investor Relations” page on our website or through SEC’s website.

Minerva Surgical uses AST Financial as its transfer agent and contact information is provided below.

American Stock Transfer & Trust Company, LLC
48 Wall Street, 22nd Floor
New York, New York 10005

Please see the Events section of our website for a listing of upcoming earnings announcements and other key events.

The IPO was underwritten and managed by JP Morgan, Piper Sandler, UBS, and SVB Leerink.

If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, address changes should be submitted in writing by U.S. Mail to our transfer agent:

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219